PALATIN TECHNOLOGIES, INC. Cash and Cash Equivalents
PALATIN TECHNOLOGIES, INC. (PTN) had Cash and Cash Equivalents of $10.16 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-05-13
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $10.16M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $14.48M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $1.27M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $2.56M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-03-31 | $10.16M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $14.48M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $1.27M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.56M 10-Q · filed 2026-05-13 |
| 2025-03-31 | $2.52M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $2.38M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $9.53M 10-K · filed 2024-09-30 |
| 2024-03-31 | $21.49M 10-Q · filed 2024-05-15 |
| 2024-01-31 | $9.22M 10-Q · filed 2024-02-14 |
| 2023-12-31 | $9.49M 10-Q · filed 2024-02-14 |
| 2023-10-31 | $4.57M 10-Q · filed 2023-11-14 |
| 2023-09-30 | $5.52M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $10.98M 10-K · filed 2023-09-28 |
| 2023-03-31 | $19.63M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $21.18M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $21.19M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $29.94M 10-Q · filed 2023-05-15 |
| 2022-03-31 | $37.72M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $47.33M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $53.42M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $60.10M 10-K · filed 2022-09-22 |
| 2021-03-31 | $68.64M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $72.16M 10-Q · filed 2022-02-14 |
| 2020-09-30 | $86.59M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $82.85M 10-K · filed 2022-09-22 |
| 2020-03-31 | $88.95M 10-Q · filed 2021-05-14 |
| 2019-12-31 | $91.46M 10-Q · filed 2021-02-16 |
| 2019-09-30 | $96.70M 10-Q · filed 2020-11-16 |
| 2019-06-30 | $43.51M 10-K · filed 2021-09-28 |
| 2019-03-31 | $19.81M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $24.66M 10-Q · filed 2020-02-10 |
| 2018-09-30 | $32.62M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $38.00M 10-K · filed 2020-09-25 |
| 2018-03-31 | $25.74M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $34.96M 10-Q · filed 2019-02-11 |
| 2017-09-30 | $39.71M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $40.20M 10-K · filed 2020-09-25 |
| 2017-03-31 | $54.51M 10-Q · filed 2018-05-14 |
| 2016-12-31 | $12.11M 10-Q · filed 2018-02-12 |
| 2016-09-30 | $8.87M 10-Q · filed 2017-11-13 |
| 2016-06-30 | $8.00M 10-K · filed 2019-09-12 |
| 2016-03-31 | $21.77M 10-Q · filed 2017-05-15 |
| 2015-12-31 | $31.99M 10-Q · filed 2017-02-10 |
| 2015-09-30 | $47.52M 10-Q · filed 2016-11-14 |
| 2015-06-30 | $27.30M 10-K · filed 2018-09-13 |
| 2015-03-31 | $36.73M 10-Q · filed 2016-05-16 |
| 2014-12-31 | $42.69M 10-Q · filed 2016-02-12 |
| 2014-09-30 | $17.79M 10-Q · filed 2015-11-12 |
| 2014-06-30 | $12.18M 10-K · filed 2017-09-25 |
| 2014-03-31 | $16.72M 10-Q · filed 2015-05-12 |
| 2013-12-31 | $16.68M 10-Q · filed 2015-02-12 |
| 2013-09-30 | $18.59M 10-Q · filed 2014-11-14 |
| 2013-06-30 | $19.17M 10-K · filed 2016-09-19 |
| 2013-03-31 | $23.54M 10-Q · filed 2014-05-12 |
| 2012-12-31 | $32.85M 10-Q · filed 2014-02-14 |
| 2012-09-30 | $33.46M 10-Q · filed 2013-11-13 |
| 2012-06-30 | $3.83M 10-K · filed 2015-09-18 |
| 2012-03-31 | $8.77M 10-Q · filed 2013-05-13 |
| 2011-12-31 | $11.90M 10-Q · filed 2013-02-13 |
| 2011-09-30 | $14.88M 10-Q · filed 2012-11-14 |
| 2011-06-30 | $18.87M 10-K · filed 2014-09-12 |
| 2011-03-31 | $22.03M 10-Q · filed 2012-05-14 |
| 2010-12-31 | $1.73M 10-Q · filed 2012-02-14 |
| 2010-09-30 | $1.23M 10-Q · filed 2011-11-14 |
| 2010-06-30 | $5.41M 10-K · filed 2013-09-27 |
| 2009-06-30 | $4.38M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |